These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18239262)

  • 21. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor expression and vascularity in renal allograft biopsies.
    Sarioğlu S; Celik A; Erşen A; Uçer I; Sağlam F; Camsari T; Gülay H
    Transplant Proc; 2008; 40(1):178-80. PubMed ID: 18261579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.
    Fox CH; Swanson A; Kahn LS; Glaser K; Murray BM
    J Am Board Fam Med; 2008; 21(6):522-30. PubMed ID: 18988719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Kulaputana O; Futrakul P; Chavanakul A; Deekajorndech T
    Ren Fail; 2011; 33(3):312-5. PubMed ID: 21401356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of endothelial progenitor cells in acute kidney injury.
    Becherucci F; Mazzinghi B; Ronconi E; Peired A; Lazzeri E; Sagrinati C; Romagnani P; Lasagni L
    Blood Purif; 2009; 27(3):261-70. PubMed ID: 19218794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of endothelial progenitor cells in renal disease].
    Lazzeri E; Angelotti ML; Ballerini L; Becherucci F; Mazzinghi B; Parente E; Ronconi E; Sagrinati C; Romagnani P; Lasagni L
    G Ital Nefrol; 2008; 25(5):537-46. PubMed ID: 18828116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.
    Pawlak K; Mysliwiec M; Pawlak D
    Cytokine; 2008 Jul; 43(1):98-101. PubMed ID: 18455421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality.
    Van Craenenbroeck EM; Denollet J; Paelinck BP; Beckers P; Possemiers N; Hoymans VY; Vrints CJ; Conraads VM
    Clin Sci (Lond); 2009 Jul; 117(4):165-72. PubMed ID: 19173675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of COMP-angiopoietin-1 on cyclosporine-induced renal injury in mice.
    Lee S; Kim W; Kim DH; Moon SO; Jung YJ; Lee AS; Kang KP; Jang KY; Lee SY; Sung MJ; Koh GY; Park SK
    Nephrol Dial Transplant; 2008 Sep; 23(9):2784-94. PubMed ID: 18463324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor.
    Faleo G; Neto JS; Kohmoto J; Tomiyama K; Shimizu H; Takahashi T; Wang Y; Sugimoto R; Choi AM; Stolz DB; Carrieri G; McCurry KR; Murase N; Nakao A
    Transplantation; 2008 Jun; 85(12):1833-40. PubMed ID: 18580478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal microcirculation].
    Tamaki T
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():321-4. PubMed ID: 11026283
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.